急性COPD恶化的进展:澄清传染性和非传染性因素的特定免疫机制
Yadan Tu1,2, Yong Chen1,2, Xuanhan Li1,2
1Department of Classic Chinese Medicine, The First Affiliated Hospital of Chongqing University of Chinese Medicine, Chongqing, China.
Therapeutic advances in respiratory disease
|March 18, 2025
概括
慢性阻塞性肺病 (AECOPD) 的急性恶化是住院的主要原因. 了解免疫机制和区分传染性和非传染性因素对于有效的AECOPD治疗至关重要.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 微生物学 微生物学
背景情况:
- 慢性阻塞性肺病 (AECOPD) 的急性恶化导致大量住院和死亡.
- 临床滥用抗生素有助于细菌耐药性,使AECOPD管理复杂化.
- 目前的治疗方法有限,特别是非传染性AECOPD,这对临床提出了挑战.
研究的目的:
- 系统地讨论AECOPD背后的免疫系统机制.
- 要区分AECOPD的传染性和非传染性触发因素.
- 审查AECOPD目前的诊断和治疗策略.
主要方法:
- 综合文献综述. 这是一个全面的文献综述.
- 在AECOPD中系统地讨论免疫激活,炎症细胞招募和炎症反应.
- 分析现有的有针对性的诊断和治疗方法.
主要成果:
- AECOPD涉及复杂的免疫系统激活和炎症细胞招募.
- 传染性和非传染性AECOPD触发器之间存在关键差异.
- 目前的文献提供了对不同疾病阶段的有针对性的干预措施的见解.
结论:
- 对AECOPD的免疫机制的彻底理解对于临床实践至关重要.
- 区分传染性和非传染性因素对于适当的AECOPD管理至关重要.
- 本综述为AECOPD的临床预防和治疗提供了新的策略.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
COPD: Management Using Bronchodilators and Corticosteroids
166
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
166
COPD: Pathogenesis and Clinical Features
219
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
219
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K


